146537-94-2

Upstream product

• 1629-60-3 1-hexene-3-one 
• 100-01-6 4-nitro-aniline 

Downstream Products

• 146538-02-5 2-methoxymethyl-4-propyl-5-(4-nitrobenzyl)thiazole 
• 146537-99-7 ethyl 4-[[4-propyl-5-(4-nitrobenzyl)thiazol-2-yl]mercapto]butyrate 
• 146538-12-7 2-ethoxycarbonylaminomethyl-5-(4-nitrobenzyl)-4-propylthiazole 
• 146538-33-2 2-methylthiomethyl-5-(4-nitrobenzyl)-4-propylthiazole 
• 146538-01-4 ethyl 4-[[4-propyl-5-(4-(2-sulfobenzoylamino)benzyl)thiazol-2-yl]mercapto]butyrate 
• 146538-00-3 ethyl 4-[[4-propyl-5-(4-aminobenzyl)thiazol-2-yl]mercapto]butyrate 
• 146538-03-6 2-methoxymethyl-4-propyl-5-(4-aminobenzyl)thiazole 
• 146537-96-4 2-methyl-4-propyl-5-(4-aminobenzyl)thiazole 
• 146538-34-3 2-methylthiomethyl-5-(4-aminobenzyl)-4-propylthiazole 

Relevant academic research and scientific papers

Thiazole derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present

The present invention relates to the derivatives of formula (I): STR1 and their addition salts, and to their use in therapeutics, especially for the treatment of cardiovascular diseases and in particular for the treatment of hypertension and cardiac insufficiency.